Cancer‐associated mutations in endometriosis reframe a benign disease through molecular oncology
Open Access
- 23 September 2026
- journal article
- review article
- Published by Wiley in Molecular Oncology
Abstract
Endometriosis is a benign yet debilitating condition, and its molecular complexity remains unexplored. Although clinically recognized, its genetic landscape has long been overlooked. This review analyses cancer‐associated mutations (CAMs) identified in endometriotic lesions, revealing parallels with malignancy. Recurrent mutations in key oncogenic and tumour suppressor genes— PIK3CA , CTNNB1 , KRAS , PTEN and ARID1A —emerge with patterns distinct from cancer, yet suggesting shared mechanisms. Despite the limited genomic data, these findings position endometriosis as a valuable model for investigating early tumour‐like processes. By reframing endometriosis through the lens of molecular oncology, this study offers new insights into its pathogenesis and proposes a translational framework for advancing diagnostics and understanding disease progression at the benign–malignant interface.Keywords
This publication has 35 references indexed in Scilit:
- The human endometrium: atlases, models, and prospectsCurrent Opinion in Genetics & Development, 2025
- Randomized, controlled, proof-of-concept trial of gefapixant for endometriosis-related painFertility and Sterility, 2024
- Decreased expression of KLF6 in ectopic endometrial stromal cells contributes to endometriosis progression by targeting CTNNB1Cellular Signalling, 2024
- KRAS mutations and endometriosis burden of diseaseThe Journal of Pathology: Clinical Research, 2023
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancerESMO Open, 2023
- Endometriosis Classification, Staging and Reporting Systems: A Review on the Road to a Universally Accepted Endometriosis ClassificationJournal of Minimally Invasive Gynecology, 2021
- Targeting ARID1A mutations in cancerCancer Treatment Reviews, 2021
- Alterations in β-catenin, microsatellite instability, and HNF-1β levels are independently associated with ovarian endometriosis–associated tumorigenesisHuman Pathology, 2019
- Distinguishing the progression of an endometrioma: Benign or malignant?European Journal of Obstetrics & Gynecology and Reproductive Biology, 2018
- Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal EndometriumCell Reports, 2018